Slovenija - slovenščina - JAZMP (Javna agencija RS za zdravila in medicinske pripomočke)

baxter d.o.o. - glukoza, brezvodna; kalcijev klorid dihidrat; magnezijev klorid heksahidrat; natrijev (s)-laktat; natrijev hidrogenkarbonat; natrijev klorid - raztopina za peritonealno dializo - glukoza, brezvodna 38,6 g / 1000 ml  kalcijev klorid dihidrat0,184 g / 1000 ml  magnezijev klorid heksahidrat0,051 g / 1000 ml  natrijev (s)-laktat1,68 g / 1000 ml  natrijev hidrogenkarbonat2,1 g / 1000 ml  natrijev klorid5,38 g / 1000 ml; kalcijev klorid dihidrat 0,184 g / 1000 ml  magnezijev klorid heksahidrat0,051 g / 1000 ml  natrijev (s)-laktat1,68 g / 1000 ml  natrijev hidrogenkarbonat2,1 g / 1000 ml  natrijev klorid5,38 g / 1000 ml; magnezijev klorid heksahidrat 0,051 g / 1000 ml  natrijev (s)-laktat1,68 g / 1000 ml  natrijev hidrogenkarbonat2,1 g / 1000 ml  natrijev klorid5,38 g / 1000 ml; natrijev (s)-laktat 1,68 g / 1000 ml  natrijev hidrogenkarbonat2,1 g / 1000 ml  natrijev klorid5,38 g / 1000 ml; natrijev hidrogenkarbonat 2,1 g / 1000 ml  natrijev klorid5,38 g / 1000 ml; natrijev klorid 5,38 g / 1000 ml - hipertonične raztopine

Evropska unija - slovenščina - EMA (European Medicines Agency)

takeda pharma a/s - fentanil citrat - pain; cancer - analgetiki - zdravilo instanyl je indicirano za zdravljenje prebijajoče bolečine pri odraslih, ki že prejemajo vzdrževalno opioidno terapijo za kronično bolečino pri raku. prebojna bolečina je prehodno poslabšanje bolečine, ki se pojavi na ozadju kontinuirane bolečine, ki jo sicer nadzira.  patients receiving maintenance opioid therapy are those who are taking at least 60 mg of oral morphine daily, at least 25 micrograms of transdermal fentanyl per hour, at least 30 mg oxycodone daily, at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another opioid for a week or longer.

Evropska unija - slovenščina - EMA (European Medicines Agency)

roche registration gmbh - metoksi polietilen glikol-epoetin beta - anemia; kidney failure, chronic - antianemični preparati - treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in adult patients (see section 5. treatment of symptomatic anaemia associated with chronic kidney disease (ckd) in paediatric patients from 3 months to less than 18 years of age who are converting from another erythropoiesis stimulating agent (esa) after their haemoglobin level was stabilised with the previous esa (see section 5.

Evropska unija - slovenščina - EMA (European Medicines Agency)

nordic group b.v. - tegafur, gimeracil, oteracil - Želodne neoplazme - antineoplastična sredstva - teysuno is indicated in adults:- for the treatment of advanced gastric cancer when given in combination with cisplatin (see section 5. - as monotherapy or in combination with oxaliplatin or irinotecan, with or without bevacizumab, for the treatment of patients with metastatic colorectal cancer for whom it is not possible to continue treatment with another fluoropyrimidine due to hand-foot syndrome or cardiovascular toxicity that developed in the adjuvant or metastatic setting.

Evropska unija - slovenščina - EMA (European Medicines Agency)

bial portela & companhia s.a. - opikapon - parkinsonova bolezen - anti-parkinsonska zdravila - ontilyv is indicated as adjunctive therapy to preparations of levodopa/ dopa decarboxylase inhibitors (ddci) in adult patients with parkinson’s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.

Evropska unija - slovenščina - EMA (European Medicines Agency)

accord healthcare s.l.u. - doxorubicin hydrochloride, liposomal - ovarian neoplasms; sarcoma, kaposi; multiple myeloma - doxorubicin - zolsketil pegylated liposomal is a medicine used to treat the following types of cancer in adults:• breast cancer that has spread to other parts of the body in patients at risk of heart problems. zolsketil pegylated liposomal is used on its own for this disease;• advanced ovarian cancer in women whose previous treatment including a platinum-based cancer medicine has stopped working;• multiple myeloma (a cancer of the white blood cells in the bone marrow), in patients with progressive disease who have received at least one other treatment in the past and have already had, or are unsuitable for, a bone marrow transplantation. zolsketil pegylated liposomal is used in combination with bortezomib (another cancer medicine);• kaposi’s sarcoma in patients with aids who have a very damaged immune system. kaposi’s sarcoma is a cancer that causes abnormal tissue to grow under the skin, on moist body surfaces or on internal organs. zolsketil pegylated liposomal contains the active substance doxorubicin and is a ‘hybrid medicine’. this means that it is similar to a ‘reference medicine’ containing the same active substance called adriamycin. however, in zolsketil pegylated liposomal the active substance is enclosed in tiny fatty spheres called liposomes, whereas this is not the case for adriamycin.

Evropska unija - slovenščina - EMA (European Medicines Agency)

astrazeneca ab - tezepelumab - astma - zdravila za obstruktivne pljučne bolezni, - tezspire is indicated as an add-on maintenance treatment in adults and adolescents 12 years and older with severe asthma who are inadequately controlled despite high dose inhaled corticosteroids plus another medicinal product for maintenance treatment.